Fundz Deep Dive
Everything you need to win Andrea James — in one platform.
Who to reach, what to say, and why now on Andrea James — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Andrea James — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Oncocyte Corporation Appoints Andrea James As Chief Financial Officer and Principal Financial Officer
PUBLIC · IMDXJun 17, 2024•almost 2 years ago
Position
Chief Financial Officer
Company
OncoCyte Corp
IrvineBiotechnologyHealth CareGeneticsHealth DiagnosticsDescription
Oncocyte Corporation has appointed Andrea James as their new Chief Financial Officer and Principal Financial Officer, effective June 17, 2024. Ms. James brings a wealth of experience to the role, with a rich background in investor relations and corporate strategy.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months